American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about 3M (NYSE:MMM) Now Covered by StockNews.com

3M (NYSE:MMM) Now Covered by StockNews.com

StockNews.com began coverage on shares of 3M (NYSE:MMM – Get Free Report) in a report issued on Tuesday. The brokerage set a “buy” rating on the conglomerate’s stock. MMM has been the subject of several other... More of this article »
Image about Southwestern Energy (NYSE:SWN) Now Covered by StockNews.com

Southwestern Energy (NYSE:SWN) Now Covered by StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Southwestern Energy (NYSE:SWN – Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a “hold” rating on the energy company’s... More of this article »
Image about Analyzing KORU Medical Systems (NASDAQ:KRMD) and AngioDynamics (NASDAQ:ANGO)

Analyzing KORU Medical Systems (NASDAQ:KRMD) and AngioDynamics (NASDAQ:ANGO)

KORU Medical Systems (NASDAQ:KRMD – Get Free Report) and AngioDynamics (NASDAQ:ANGO – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based... More of this article »
Image about BTIG Research Increases LifeMD (NASDAQ:LFMD) Price Target to $13.00

BTIG Research Increases LifeMD (NASDAQ:LFMD) Price Target to $13.00

LifeMD (NASDAQ:LFMD – Get Free Report) had its price target lifted by analysts at BTIG Research from $11.00 to $13.00 in a research note issued on Friday, Benzinga reports. The firm currently has a “buy” rating on... More of this article »
Image about Kezar Life Sciences’ (KZR) Buy Rating Reaffirmed at HC Wainwright

Kezar Life Sciences’ (KZR) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Kezar Life Sciences (NASDAQ:KZR – Free Report) in a research note published on Friday, Benzinga reports. They currently have a $20.00 price objective on the stock. Kezar... More of this article »
Image about Century Therapeutics (NASDAQ:IPSC) PT Raised to $24.00 at Canaccord Genuity Group

Century Therapeutics (NASDAQ:IPSC) PT Raised to $24.00 at Canaccord Genuity Group

Century Therapeutics (NASDAQ:IPSC – Get Free Report) had its price target increased by analysts at Canaccord Genuity Group from $22.00 to $24.00 in a report issued on Friday, Benzinga reports. The firm currently has a “buy”... More of this article »
Image about HC Wainwright Reiterates Buy Rating for ImmunoPrecise Antibodies (NASDAQ:IPA)

HC Wainwright Reiterates Buy Rating for ImmunoPrecise Antibodies (NASDAQ:IPA)

ImmunoPrecise Antibodies (NASDAQ:IPA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued on Friday, Benzinga reports. They presently have a $9.00... More of this article »
Image about Host Hotels & Resorts (NASDAQ:HST) PT Raised to $25.00

Host Hotels & Resorts (NASDAQ:HST) PT Raised to $25.00

Host Hotels & Resorts (NASDAQ:HST – Free Report) had its target price raised by Barclays from $23.00 to $25.00 in a research note released on Friday, Benzinga reports. They currently have an overweight rating on the stock. Other... More of this article »
Image about Chardan Capital Lowers Immuneering (NASDAQ:IMRX) Price Target to $16.00

Chardan Capital Lowers Immuneering (NASDAQ:IMRX) Price Target to $16.00

Immuneering (NASDAQ:IMRX – Get Free Report) had its target price decreased by research analysts at Chardan Capital from $21.00 to $16.00 in a report issued on Friday, Benzinga reports. The brokerage presently has a “buy”... More of this article »
Image about Robinhood Markets (NASDAQ:HOOD) PT Raised to $20.00 at Mizuho

Robinhood Markets (NASDAQ:HOOD) PT Raised to $20.00 at Mizuho

Robinhood Markets (NASDAQ:HOOD – Get Free Report) had its target price lifted by equities research analysts at Mizuho from $17.00 to $20.00 in a research note issued on Friday, Benzinga reports. The firm currently has a “buy”... More of this article »
Image about I-Mab (NASDAQ:IMAB) PT Lowered to $6.00

I-Mab (NASDAQ:IMAB) PT Lowered to $6.00

I-Mab (NASDAQ:IMAB – Get Free Report) had its price target lowered by research analysts at Needham & Company LLC from $8.00 to $6.00 in a research note issued on Friday, Benzinga reports. The firm presently has a “buy”... More of this article »
Image about OneWater Marine (NASDAQ:ONEW) Earns Neutral Rating from DA Davidson

OneWater Marine (NASDAQ:ONEW) Earns Neutral Rating from DA Davidson

DA Davidson reaffirmed their neutral rating on shares of OneWater Marine (NASDAQ:ONEW – Free Report) in a report released on Friday morning, Benzinga reports. The brokerage currently has a $27.00 price target on the stock. A... More of this article »
Image about SoundThinking’s (SSTI) “Overweight” Rating Reiterated at Cantor Fitzgerald

SoundThinking’s (SSTI) “Overweight” Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of SoundThinking (NASDAQ:SSTI – Free Report) in a report published on Friday morning, Benzinga reports. The brokerage currently has a $25.00 price target on the stock. SoundThinking... More of this article »
Image about Oppenheimer Raises SEI Investments (NASDAQ:SEIC) Price Target to $77.00

Oppenheimer Raises SEI Investments (NASDAQ:SEIC) Price Target to $77.00

SEI Investments (NASDAQ:SEIC – Free Report) had its price objective lifted by Oppenheimer from $73.00 to $77.00 in a research report released on Friday, Benzinga reports. The brokerage currently has an outperform rating on the... More of this article »
Image about Silicon Motion Technology’s (SIMO) Buy Rating Reiterated at B. Riley

Silicon Motion Technology’s (SIMO) Buy Rating Reiterated at B. Riley

B. Riley reaffirmed their buy rating on shares of Silicon Motion Technology (NASDAQ:SIMO – Free Report) in a research note issued to investors on Friday, Benzinga reports. They currently have a $93.00 price objective on the... More of this article »